The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow [14]

W. Ingram; N. C. Lea; J. Cervera; U. Germing; P. Fenaux; B. Cassinat; J. J. Kiladjian; J. Varkonyi; P. Antunovic; N. B. Westwood; M. J. Arno; A. Mohamedali; J. Gaken; T. Kontou; B. H. Czepulkowski; N. A. Twine; J. Tamaska; J. Csomer; S. Benedek; N. Gattermann; E. Zipperer; A. Giagounidis; Z. Garcia-Casado; G. Sanz; Ghulam J. Mufti

doi:10.1038/sj.leu.2404215

The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow [14]

W. Ingram^*, N. C. Lea, J. Cervera, U. Germing, P. Fenaux, B. Cassinat, J. J. Kiladjian, J. Varkonyi, P. Antunovic, N. B. Westwood, M. J. Arno, A. Mohamedali, J. Gaken, T. Kontou, B. H. Czepulkowski, N. A. Twine, J. Tamaska, J. Csomer, S. Benedek, N. GattermannE. Zipperer, A. Giagounidis, Z. Garcia-Casado, G. Sanz, Ghulam J. Mufti

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

96 Citations (Scopus)

Original language	English
Pages (from-to)	1319-1321
Number of pages	3
Journal	Leukemia
Volume	20
Issue number	7
DOIs	https://doi.org/10.1038/sj.leu.2404215
Publication status	Published - Jul 2006
Externally published	Yes

Access to Document

10.1038/sj.leu.2404215

Cite this

Ingram, W., Lea, N. C., Cervera, J., Germing, U., Fenaux, P., Cassinat, B., Kiladjian, J. J., Varkonyi, J., Antunovic, P., Westwood, N. B., Arno, M. J., Mohamedali, A., Gaken, J., Kontou, T., Czepulkowski, B. H., Twine, N. A., Tamaska, J., Csomer, J., Benedek, S., ... Mufti, G. J. (2006). The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow [14]. Leukemia, 20(7), 1319-1321. https://doi.org/10.1038/sj.leu.2404215

@article{12c15f12f2e84404b69e781e8ec6cb0a,

title = "The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow [14]",

author = "W. Ingram and Lea, {N. C.} and J. Cervera and U. Germing and P. Fenaux and B. Cassinat and Kiladjian, {J. J.} and J. Varkonyi and P. Antunovic and Westwood, {N. B.} and Arno, {M. J.} and A. Mohamedali and J. Gaken and T. Kontou and Czepulkowski, {B. H.} and Twine, {N. A.} and J. Tamaska and J. Csomer and S. Benedek and N. Gattermann and E. Zipperer and A. Giagounidis and Z. Garcia-Casado and G. Sanz and Mufti, {Ghulam J.}",

year = "2006",

month = jul,

doi = "10.1038/sj.leu.2404215",

language = "English",

volume = "20",

pages = "1319--1321",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer, Springer Nature",

number = "7",

}

Ingram, W, Lea, NC, Cervera, J, Germing, U, Fenaux, P, Cassinat, B, Kiladjian, JJ, Varkonyi, J, Antunovic, P, Westwood, NB, Arno, MJ, Mohamedali, A, Gaken, J, Kontou, T, Czepulkowski, BH, Twine, NA, Tamaska, J, Csomer, J, Benedek, S, Gattermann, N, Zipperer, E, Giagounidis, A, Garcia-Casado, Z, Sanz, G & Mufti, GJ 2006, 'The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow [14]', Leukemia, vol. 20, no. 7, pp. 1319-1321. https://doi.org/10.1038/sj.leu.2404215

TY - JOUR

T1 - The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow [14]

AU - Ingram, W.

AU - Lea, N. C.

AU - Cervera, J.

AU - Germing, U.

AU - Fenaux, P.

AU - Cassinat, B.

AU - Kiladjian, J. J.

AU - Varkonyi, J.

AU - Antunovic, P.

AU - Westwood, N. B.

AU - Arno, M. J.

AU - Mohamedali, A.

AU - Gaken, J.

AU - Kontou, T.

AU - Czepulkowski, B. H.

AU - Twine, N. A.

AU - Tamaska, J.

AU - Csomer, J.

AU - Benedek, S.

AU - Gattermann, N.

AU - Zipperer, E.

AU - Giagounidis, A.

AU - Garcia-Casado, Z.

AU - Sanz, G.

AU - Mufti, Ghulam J.

PY - 2006/7

Y1 - 2006/7

UR - http://www.scopus.com/inward/record.url?scp=33745213401&partnerID=8YFLogxK

U2 - 10.1038/sj.leu.2404215

DO - 10.1038/sj.leu.2404215

M3 - Letter

C2 - 16617322

AN - SCOPUS:33745213401

SN - 0887-6924

VL - 20

SP - 1319

EP - 1321

JO - Leukemia

JF - Leukemia

IS - 7

ER -

The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow [14]

Access to Document

Other files and links

Cite this